✦ LIBER ✦

COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VS. HUMAN PREMIX INSULIN IN TYPE 2 DIABETES FROM THE PAYER’S PERSPECTIVE IN BULGARIA

✍ Scribed by Valov, Vasil; Palmer, James; Czech, Marcin; Savova, Alexandra; Petrova, Guenka

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB27 COST-EFFECTIVENESS OF BIPHASIC INS

✍ M Lynch; H Scheijbeler; R Kotchie; S Nielsen; J White; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB23 COST-EFFECTIVENESS OF BIPHASIC INS

✍ M Aristides; R Kotchie; S Nielsen; C Townsend; WJ Valentine; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

DB1 PROJECTED COST-EFFECTIVENESS OF BIPH

✍ M Aagren; TL Thomsen; VK Knudsen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PDB30 EVALUATING THE COST-EFFECTIVENESS

✍ D Tucker; WJ Valentine; S Nielsen; C Townsend; R Kotchie; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Short And Long-Term Cost-Effectiveness O

✍ Home, P.D.; Soewondo, P.; Hussein, Z.; Shafie, A.A.; AlRaddady, K.; Baadbad, R.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Insulin therapy in type 2 diabetes patie

✍ J. A. Ray; W. J. Valentine; S. Roze; L. Nicklasson; D. Cobden; P. Raskin; A. Gar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB